4
Changes in Ownership
Sionna Therapeutics, Inc. Filed Acc 0001451612-25-000012
Director sold 88,878 shares at an average $34.22 ($3,041,683)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Booth Bruce · Director
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-21 | Sale : show line 1 in the form 10b5-1 | −22,339 | $32.69 | $730,262 | 2,360,156 | I |
| 2025-10-21 | Sale : show line 2 in the form 10b5-1 | −4,688 | $32.69 | $153,251 | 697,297 | I |
| 2025-10-21 | Sale : show line 3 in the form 10b5-1 | −19,948 | $33.87 | $675,639 | 2,340,208 | I |
| 2025-10-21 | Sale : show line 4 in the form 10b5-1 | −4,187 | $33.87 | $141,814 | 693,110 | I |
| 2025-10-21 | Sale : show line 5 in the form 10b5-1 | −5,763 | $34.91 | $201,186 | 2,334,445 | I |
| 2025-10-21 | Sale : show line 6 in the form 10b5-1 | −1,210 | $34.91 | $42,241 | 691,900 | I |
| 2025-10-21 | Sale : show line 7 in the form 10b5-1 | −25,327 | $35.69 | $903,921 | 2,309,118 | I |
| 2025-10-21 | Sale : show line 8 in the form 10b5-1 | −5,316 | $35.69 | $189,728 | 686,584 | I |
| 2025-10-21 | Sale : show line 9 in the form 10b5-1 | −83 | $36.42 | $3,023 | 2,309,035 | I |
| 2025-10-21 | Sale : show line 10 in the form 10b5-1 | −17 | $36.42 | $619 | 686,567 | I |
| Open-market sales · 88,878 sh · avg $34.22 · $3,041,683 | ||||||
Loading xslF345X05/form4-10212025_091059.xml…